Items where authors include "Slevin, F."

Article

Slevin, F. orcid.org/0000-0002-7176-904X, Hudson, E.M. orcid.org/0000-0001-8758-7163, Boele, F.W. et al. (25 more authors) (2025) APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health – study protocol paper for a phase III multicentre, open-label randomised controlled trial. BMJ Open, 15 (2). e097810. ISSN 2044-6055

Slevin, F. orcid.org/0000-0002-7176-904X, Alexander, S., Brown, S.R. orcid.org/0000-0002-7975-7537 et al. (20 more authors) (2024) Pelvis or involved node treatment: eradicating recurrence in prostate cancer (POINTER-PC) – study protocol paper for a phase III multicentre, open-label randomised controlled trial. BMJ Open, 14. e095560. ISSN 2044-6055

Slevin, F. orcid.org/0000-0002-7176-904X, Alexander, S., Brown, S.R. orcid.org/0000-0002-7975-7537 et al. (20 more authors) (2024) Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) – study protocol paper for a phase III multicentre, open-label randomised controlled trial. BMJ Open, 14 (12). e095560. ISSN 2044-6055

Slevin, F. orcid.org/0000-0002-7176-904X, Zattoni, F., Checcucci, E. et al. (27 more authors) (2024) A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer. European Urology Oncology, 7 (4). pp. 677-696. ISSN 2588-9311

Iyizoba-Ebozue, Z., Nicklin, E., Price, J. orcid.org/0000-0002-3325-2488 et al. (9 more authors) (2024) “Why am I still suffering?”: Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapy. Technical Innovations and Patient Support in Radiation Oncology, 30. 100241. ISSN 2405-6324

Hudson, E.M. orcid.org/0000-0001-8758-7163, Noutch, S., Webster, J. et al. (15 more authors) (2024) Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) – protocol for a multi-centre open-label randomised trial. BMJ Open, 14 (3). e078926. ISSN 2044-6055

Hudson, E.M. orcid.org/0000-0001-8758-7163, Slevin, F. orcid.org/0000-0002-7176-904X, Biscombe, K. orcid.org/0009-0002-9298-3093 et al. (7 more authors) (2024) Hitting the Target: Developing High-quality Evidence for Proton Beam Therapy Through Randomised Controlled Trials. Clinical Oncology, 36 (2). pp. 70-79. ISSN 0936-6555

Iyizobane Ebozue, Z., Prestwich, R., Brown, S. orcid.org/0000-0002-7975-7537 et al. (7 more authors) (2023) Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic review. Radiotherapy and Oncology, 188. 109863. ISSN 0167-8140

Iyizobane-Ebozue, Z., Prestwich, R., Brown, S. et al. (7 more authors) (2023) Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: a systematic review. Radiotherapy and Oncology, 188. 109863. ISSN 0167-8140

Slevin, F., Beasley, M., Zhong, J. orcid.org/0000-0001-5325-3739 et al. (5 more authors) (2022) A feasibility trial of Buscopan to improve cone-beam CT during abdominal/pelvic SABR. Clinical Oncology (Wormald abstract Competition 2021), 34 (2). ISSN 0936-6555

Slevin, F. orcid.org/0000-0002-7176-904X, Aitken, K., Alongi, F. et al. (24 more authors) (2021) An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation. Radiotherapy and Oncology, 164. pp. 104-114. ISSN 0167-8140

Slevin, F. orcid.org/0000-0002-7176-904X, Thompson, C.M., Speight, R. et al. (3 more authors) (2021) Ultra hypofractionated extended nodal irradiation using volumetric modulated arc therapy for oligorecurrent pelvic nodal prostate cancer. Medical Dosimetry, 46 (4). pp. 411-418. ISSN 0958-3947

Slevin, F. orcid.org/0000-0002-7176-904X, Beasley, M., Speight, R. et al. (5 more authors) (2020) Evaluation of clinician contouring for pancreatic stereotactic ablative radiotherapy (SABR) during an RCR contouring workshop. Clinical Oncology, 32 (Supplement 1). E3. ISSN 0936-6555